Subveho, LLC provides Venture Capitalists, angel investors, academic-affiliated institutions, and other early stage pharmaceutical investors an experienced and innovative team to drive focused, efficient translational development of pharmaceutical assets. We offer pre-investment diligence to investors to ensure business strategy is aligned with operational feasibility. Post-investment, we provide the management team to drive the asset through value inflection points, broaden the network of potential partners and investors, and progress the program to its business and scientific goals.

By de-centralizing the management team from individual assets, Subveho is able to progress early stage pharmaceutical programs efficiently, in a cost effective manner, while still retaining the benefits of an established company. Subveho provides a team of experts, experienced in working together in the start-up space, whose incentives are aligned with the Investors and founders.

Our Vision

• • •

To accelerate the success of innovative pharmaceutical assets and maximize stakeholder return on investment.

Our Mission

• • •

We apply expertise gained from start-up, CRO, large pharma and discovery settings

team icon

Provide investors an expert, lean, and cohesive virtual management team

team icon

Design and lead customized development programs that prioritize value inflection opportunities

team icon

Achieve efficiencies in cost and maximize shared knowledge by applying broad skillsets across multiple programs